17 Aug 2021 Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science Member news
15 Jul 2021 Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study Member news
15 Jul 2021 Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation Member news
12 Jul 2021 Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis Member news
29 Jun 2021 imec’s ultrasound sensor technology yields accurate pulse wave velocity and blood pressure values Member news
08 Jun 2021 OXURION completes patient enrollment for Part A of Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Member news
20 May 2021 Eurofins Genomics meets global demand for SARS-CoV-2 full genome sequencing, with over 100,000 sequenced samples in less than 8 weeks Member news
19 May 2021 Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
